Showing results (121-130 of 239) with videos related to
Sort By:
Pageof 24
Kidney International|January 10, 2014
Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancerAzzour D Hazzan, Hitesh H Shah, Susana Hong, et al.Journal of Nephrology|February 9, 2022
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidenceDaniel W Coyne, Stuart M Sprague, Marc Vervloet, et al.Clinical Journal of the American Society of Nephrology : CJASN|June 27, 2008
Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter studyRajnish Mehrotra, Kevin J Martin, Steven Fishbane, et al.Kidney & Blood Pressure Research|December 17, 2025
Influence of concomitant opioids on difelikefalin treatment outcomes in adults with moderate-to-severe pruritus on maintenance hemodialysis: Exploratory analysesJames O Burton, Satkiran Grewal, Thilo Schaufler, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2002
Pheochromocytoma multisystem crisis in a patient with multiple endocrine neoplasia type IIB and pyelonephritisChristopher Caputo, Steven Fishbane, Lawrence Shapiro, et al.Nephron. Clinical Practice|January 18, 2007
Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patientsGeorges Saab, Daniel O Young, Yekaterina Gincherman, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2002
Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patientsDaniel W Coyne, Marvin Grieff, Shubhada N Ahya, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL studyDaniel W Coyne, Dennis L Andress, Michael J Amdahl, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2004
Sodium ferric gluconate complex in haemodialysis patients: a prospective evaluation of long-term safetyBeckie Michael, Daniel W Coyne, Vaughn W Folkert, et al.Clinical Journal of the American Society of Nephrology : CJASN|April 4, 2008
A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patientsSteven C Cheng, Daniel O Young, Yihung Huang, et al.Pageof 24